Bepridil
From Self-sufficiency
File:Bepridil.svg | |
Systematic (IUPAC) name | |
---|---|
N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Oral |
Pharmacokinetic data | |
Bioavailability | Well absorbed |
Protein binding | 99% |
Metabolism | Hepatic, CYP3A4-mediated |
Biological half-life | 42 hours |
Excretion | Renal |
Identifiers | |
CAS Number | 64706-54-3 |
ATC code | C08EA02 (WHO) |
PubChem | CID 2351 |
DrugBank | APRD00727 |
ChemSpider | 2261 |
Chemical data | |
Formula | C24H34N2O |
Molar mass | 366.54 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
Bepridil (trade name Vascor) is a calcium channel blocker once used to treat angina. It is no longer sold in the United States.
It is nonselective.[1]
It has been discussed as a possible option in the treatment of atrial fibrillation.[2]
It has been implicated in causing the ventricular arrythmia [Torsade de Pointes] Torsade de pointes.
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- 2Fix
- Calcium channel blockers
- Pyrrolidines
- Amines
- Ethers
- Cardiovascular system drug stubs